Literature DB >> 21544957

The identification of and rationale for drugs which act at the motilin receptor.

Susan M Westaway1, Gareth J Sanger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 21544957     DOI： 10.1016/s0079-6468(09)04802-4

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  9 in total

1.  Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1.

Authors:  Tomoki Maekawa; Hikaru Tamura; Hisanori Domon; Takumi Hiyoshi; Toshihito Isono; Daisuke Yonezawa; Naoki Hayashi; Naoki Takahashi; Koichi Tabeta; Takeyasu Maeda; Masataka Oda; Athanasios Ziogas; Vasileia Ismini Alexaki; Triantafyllos Chavakis; Yutaka Terao; George Hajishengallis
Journal:  JCI Insight       Date:  2020-08-06

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.

Authors:  John Broad; Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

4.  Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists.

Authors:  J Broad; S Mukherjee; M Samadi; J E Martin; G E Dukes; G J Sanger
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 5.  Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.

Authors:  Gareth J Sanger; John B Furness
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

6.  The hungry stomach: physiology, disease, and drug development opportunities.

Authors:  Gareth J Sanger; Per M Hellström; Erik Näslund
Journal:  Front Pharmacol       Date:  2011-02-18       Impact factor: 5.810

Review 7.  Why is motilin active in some studies with mice, rats, and guinea pigs, but not in others? Implications for functional variability among rodents.

Authors:  Gareth J Sanger
Journal:  Pharmacol Res Perspect       Date:  2022-04

Review 8.  Translational neuropharmacology: the use of human isolated gastrointestinal tissues.

Authors:  G J Sanger; J Broad; V Kung; C H Knowles
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

9.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.

Authors:  G J Sanger; Y Wang; A Hobson; J Broad
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.